Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Completed 16Unknown 3Withdrawn 1Terminated 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Head & Neck 3

Conditions

Breast Neoplasms 10Ovarian Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Lung Neoplasms 3Carcinoma, Ovarian Epithelial 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Rectal Neoplasms 2Melanoma 2Liver Neoplasms 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Urethral Neoplasms 1Tobacco Use Disorder 1Recurrence 1Precancerous Conditions 1Pathologic Complete Response 1Pancreatic Neoplasms 1Oligodendroglioma 1Neoplasms 1Neoplasm Metastasis 1Kidney Neoplasms 1Hirschsprung Disease 1Glioma 1Ganglion Cysts 1Gallbladder Neoplasms 1Endometrial Neoplasms 1

Interventions

Cisplatin 22Radiotherapy 15Cetuximab 12Docetaxel 11Carboplatin 10pembrolizumab 8toripalimab 6camrelizumab 6Paclitaxel 5Nivolumab 5Neoadjuvant Therapy 5Fluorouracil 5Drug Therapy 5Chemoradiotherapy 5nimotuzumab 4durvalumab 4sintilimab 3cemiplimab 3apatinib 3advexin 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Immunohistochemistry 3Celecoxib 3Blood Specimen Collection 3nedaplatin 2Therapeutics 2Tegafur 2Radiotherapy, Intensity-Modulated 2Methotrexate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Squamous Cell Carcinoma of Head and Neck × Immunohistochemistry × Clear all
NCT05832593 2023-04-27

Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy.

Assiut University

Unknown
52 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT00415298 2014-01-10

AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer

National Cancer Institute (NCI)

Phase NA Unknown
12 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00357617 2010-12-24

Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery

National Cancer Institute (NCI)

Phase 1/2 Unknown
24 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡